Hydrocortisone acetate not checked

Cristcot LLC

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
17 active
25 in total · 24 in the EU

What this is

How it works
A steroid that calms inflammation and the immune system.Corticosteroid FDA class
Tested for
Hemorrhoidal Disease
Main trialPhase 2
“The goal of this clinical trial is to evaluate the efficacy of two dosage regimens of hydrocortisone acetate suppository administered with a proprietary suppository applicator (Study Drug) compared to placebo in the treatment of hemorrhoidal disease. The primary objective is to assess HDSIM symptom improvement (worst degree) characterized by the improvement in the sum of the 8 symptom components after 2 weeks of study therapy. The secondary objective is to individually assess the HDSIM summary categories (bowel health, life impact, mental health impact, manage-ability) characterized by…”In the company’s words, NCT07909291 on ClinicalTrials.gov

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials25

TrialPhaseCompletesWhat it tests
Phase 2Not yet recruiting Jan 2027 A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 2 Study to Evaluate the Safety and Efficacy of Two Dosage Regimens of a Novel Hydrocortisone Acetate Suppository Formulation Administered With a Proprietary Suppository Applicator in Subjects With Hemorrhoidal Disease
Phase 3Expired not given Vasopressin and Steroids in addition to Adrenaline in cardiac arrest -a randomized clinical trial
Phase 2/3Authorised not given ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) with Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Phase 2Ended not given An open-label, cross-over, multi-site, prospective, phase IIb study of effects on circadian rhythms and quality of life of modifieddual-release hydrocortisone Efmody™ versus immediate-release hydrocortisone in patients with Addison’s Disease
Phase 3Authorised not given RANDOMISED EVALUATION OF COVID-19 THERAPY (RECOVERY)
Phase 3Authorised not given Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia
Phase 4Ended not given Understanding the Neurobiology of Pharmacologically-induced Acute Stress on Ethical Decisions
Phase 3/4Authorised not given A registry-based, open-label, randomized study to investigate quality-of-life with Plenadren compared with Cortison in participants aged 16-80 with newly diagnosed primary adrenal insufficiency (CORTAD)
Phase 4Ended not given REPLACE - A multi-centre, randomised, double-blinded, placebo controlled 16-weeks study to compare the effect of hydrocortisone and placebo in patients with Giant Cell Arteritis (GCA)/ Polymyalgia Rheumatica (PMR) with patient-reported symptoms of adrenal insufficiency after cessation of glucocorticoid treatment.
Phase 2Ended not given Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder
Phase 3Authorised not given International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
Phase 3Ended not given HYVAPRESS. HYdrocortisone and VAsopressine in Post-RESuscitation Syndrome
Phase 4Authorised not given Targeted glucocorticoid administration to improve safety learning in posttraumatic stress disorder patients with HPA axis dysregulation
Phase 3/4Authorised not given CRYSTAL : Comparison of topical hydrocortisone versus dexamethasone treatment for inflammatory secretions of the conjunctiva in patients with ocular prostheses
Phase 3Authorised not given Prolonged corticosteroid therapy in scheduled cardiac surgery in intermediate/high-risk patients: a prospective multicenter randomized controlled double-blind placebo-controlled study
Phase 2/3Authorised not given Perioperative hydrocortisone treatment in pancreatoduodenectomy – randomised double-blinded placebo-controlled interventional trial (PD-HYDRA)
Phase 4Ended not given RESCUE - Effect of supplemental hydrocortisone during stress in prednisolone-induced adrenal insufficiency; A multicentre, randomised, double blinded, placebo-controlled clinical trial on health-related quality of life in patients with polymyalgia rheumatica/giant cell arteritis receiving ongoing low-dose prednisolone treatment.
Phase 2/3Authorised not given Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock and/or acute respiratory failure: an open multicentric randomized phase IV study
Phase 4Authorised not given Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
Phase 3Authorised not given Vasopressin and Steroids in addition to Adrenaline in cardiac arrest -a randomized clinical trial
Phase 2Authorised not given PALETTE - Adaptive platform trial for personalisation of sepsis treatment in children and adults: a multi-national, treatable traits-guided, adaptive, exploratory, bayesian basket trial
Phase 4Not authorised not given Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections (IMPACT)
Phase 2/3Authorised not given A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)
Phase 2Authorised not given SHIELD – Swift Hydrocortisone Intervention after trauma exposure
Phase 1Authorised not given Relative oral bioavailability and tolerability of hydrocortisone from 2-dimensionally printed orodispersible films in children and adolescents with primary adrenal insufficiency (REPLACE trial)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Hydrocortisone acetate

Following is part of Solo: you see every change to Hydrocortisone acetate the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in